J14
J14 is a reversible sulfiredoxin inhibitor with an IC50 of 8.1 μM. J14 induces oxidative stress (intracellular ROS accumulation) by inhibiting sulfiredoxin, leading to cytotoxicity and cancer cell death[1].
Product Specifications
CAS Number
1043854-13-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Neuroscience-Neurodegeneration
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/j14.html
Purity
99.91
Solubility
DMSO : ≥ 125 mg/mL
Smiles
O=C(O)C1=CC=C(CSC2=NC(C3=CC=CC=C3)=CC(N4CCN(C5=CC=CC=C5Cl)CC4)=N2)C=C1
Molecular Formula
C28H25ClN4O2S
Molecular Weight
517.04
Precautions
H302, H315, H319, H335
References & Citations
[1]Kim H, et al. Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage. Free Radic Biol Med. 2016 Feb;91:264-74.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941561-100 1x 100 µL
Filaggrin (Keratinocyte Differentiation Marker) (FLG/1561), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470755-500 1x 500 µL
Human Kappa Light Chain (HP6053 + L1C1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details